Амантонио – Прививать или не прививать? или Ну, подумаешь, укол! Мифы о вакцинации (страница 12)
28.
Dórea JG et al. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months.
29.
Mitkus RJ et al. Updated aluminum pharmacokinetics following infant exposures through diet and vaccination.
30.
Jefferson T et al. Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.
31.
Nials AT et al. Mouse models of allergic asthma: acute and chronic allergen challenge.
32.
Chusid JG et al. Experimental epilepsy in the monkey following multiple intracerebral injections of alumina cream.
33.
Pali-Schöll I et al. Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitization.
34.
Vignal C et al. Gut: an underestimated target organ for aluminum.
35.
Nicholson S et al. Aluminum: a potential pro-oxidant in sunscreens/sunblocks?
36.
Srinivasan P et al. Aluminium in drinking water: an overview.
37.
Saiyed SM et al. Aluminium content of some foods and food products in the USA, with aluminium food additives.
38.
Duggan JM et al. Aluminium beverage cans as a dietary source of aluminium.
39.
Kandiah J et al. Aluminum concentrations in tissues of rats: effect of soft drink packaging.
40.
Rajwanshi P et al. Studies on aluminium leaching from cookware in tea and coffee and estimation of aluminium content in toothpaste, baking powder and paan masala.
41.
Verbeeck RM et al. Aluminium in tooth pastes and Alzheimer's disease.
42.
Veien NK et al. Systemically aggravated contact dermatitis caused by aluminium in toothpaste.
43.
Heidmann J et al. Comparative three-year caries protection from an aluminum-containing and a fluoride-containing toothpaste.
44.
Darbre PD. Aluminium, antiperspirants and breast cancer.
45.
Darbre PD. Aluminium and the human breast.
46.
Linhart C et al. Use of underarm cosmetic products in relation to risk of breast cancer: a case-control study.
47.
Davenward S et al. Silicon-rich mineral water as a non-invasive test of the 'aluminum hypothesis' in Alzheimer's disease.
48.
Oda SS. The Influence of omega3 fatty acids supplementation against aluminum-induced toxicity in male albino rats.
49.
Ekong MB et al. Neuroprotective effect of Moringa Oleifera leaf extract on aluminium-induced temporal cortical degeneration.
50.
Allagui MS et al. Pleiotropic protective roles of melatonin against aluminium-induced toxicity in rats.
51.
Yassa HA at al. Folic acid improve developmental toxicity induced by aluminum sulphates.
52.
Yousef MI at al. Propolis protection from reproductive toxicity caused by aluminium chloride in male rats.
53.
Khafaga AF. Exogenous phosphatidylcholine supplementation retrieve aluminum-induced toxicity in male albino rats.
54.
Wenting L et al. Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats.
55.
Nedzvetsky VS et al. Effects of vitamin E against aluminum neurotoxicity in rats.
56.
Sharma DR et al. Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats.
57.
Viezeliene D et al. Selective induction of IL-6 by aluminum-induced oxidative stress can be prevented by selenium.
Глава 7
Вирус папилломы человека
Вирус папилломы человека (ВПЧ) передается в основном половым путем, но также от родителей и от друзей {1}. Большинство людей заражаются им на протяжении жизни, но в 90 % случаев организм избавляется от вируса самостоятельно, без всяких симптомов, и лишь мизерный процент случаев заражения заканчивается раком шейки матки (РШМ). Существует более 170 штаммов папилломавируса. 17 из них потенциально онкогенные, некоторые приводят лишь к бородавкам.
Сегодня доступны три вакцины от ВПЧ. Гардасил – это четырехвалентная вакцина (от типов 6, 11, 16, 18), а Церварикс двухвалентная (от типов 16 и 18). Типы 16 и 18 онкогенные и «ответственны» за 70 % случаев рака шейки матки, а типы 6 и 11 могут лишь привести к бородавкам. С 2014 года существует также новая девятивалентная вакцина Гардасил‐9.